Literature DB >> 17762321

Levetiracetam-responding paroxysmal nonkinesigenic dyskinesia.

Murat Alemdar1, Pervin Iseri, Macit Selekler, Sezer Sener Komsuoğlu.   

Abstract

We report on a patient with 7-year history of short-lasting paroxysmal nonkinesigenic dyskinesia. The episodes occurred 100 to 125 times per day, lasted from 5 seconds to 3 minutes, and were not suppressed with sleeping, underlining the heterogeneity of phenomenology in paroxysmal dyskinesias. Neuroimaging studies showed calcifications in the basal ganglia, thalamus, brain stem, and subcortical and cerebellar regions. He was diagnosed with idiopathic hypoparathyroidism. After failure of valproate, he responded well to levetiracetam (1000 mg/d). This report revealed that intracerebral calcifications secondary to hypoparathyroidism could present as paroxysmal nonkinesigenic dyskinesia, and levetiracetam could be effective in this particular entity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17762321     DOI: 10.1097/wnf.0b013e31803b9415

Source DB:  PubMed          Journal:  Clin Neuropharmacol        ISSN: 0362-5664            Impact factor:   1.592


  9 in total

1.  Diagnosis and treatment of paroxysmal dyskinesias revisited.

Authors:  Iris Unterberger; Eugen Trinka
Journal:  Ther Adv Neurol Disord       Date:  2008-09       Impact factor: 6.570

Review 2.  Paroxysmal Movement Disorders: Recent Advances.

Authors:  Zheyu Xu; Che-Kang Lim; Louis C S Tan; Eng-King Tan
Journal:  Curr Neurol Neurosci Rep       Date:  2019-06-11       Impact factor: 5.081

3.  Treatment of paroxysmal dyskinesias in children.

Authors:  Jonathan W Mink
Journal:  Curr Treat Options Neurol       Date:  2015-06       Impact factor: 3.598

Review 4.  Strio-pallido-dentate calcinosis: a diagnostic approach in adult patients.

Authors:  Sara Bonazza; Chiara La Morgia; Paolo Martinelli; Sabina Capellari
Journal:  Neurol Sci       Date:  2011-04-09       Impact factor: 3.307

Review 5.  Antiseizure Drugs and Movement Disorders.

Authors:  Michel Sáenz-Farret; Marina A J Tijssen; Dawn Eliashiv; Robert S Fisher; Kapil Sethi; Alfonso Fasano
Journal:  CNS Drugs       Date:  2022-07-21       Impact factor: 6.497

6.  Paroxysmal dyskinesias.

Authors:  Shyamal H Mehta; John C Morgan; Kapil D Sethi
Journal:  Curr Treat Options Neurol       Date:  2009-05       Impact factor: 3.598

7.  Commentary.

Authors:  Murat Alemdar
Journal:  J Neurosci Rural Pract       Date:  2013-10

8.  Late onset of atypical paroxysmal non-kinesigenic dyskinesia with remote history of Graves' disease.

Authors:  Abdul Qayyum Rana; Ambreen Nadeem; Muhammad Saad Yousuf; Zakerabibi M Kachhvi
Journal:  J Neurosci Rural Pract       Date:  2013-10

9.  A Rare but Treatable Cause of Paroxysmal Nonkinesigenic Choreoathetosis.

Authors:  Sahil Mehta; Dheeraj Khurana; Gourav Jain; Vivek Lal
Journal:  Ann Indian Acad Neurol       Date:  2017 Jul-Sep       Impact factor: 1.383

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.